The matrix metallopeptidase 9 (MMP9), when activated upon both cerebral ischemia and inflammation, can degrade collagen type IV in the endothelial basement membrane, leading to disruption of the BBB and allowing entry of peripheral immune cells into the brain [21, 79, 90–94]. Here, MMP9 is linked to brain ischemia.